|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/12 | |
| A61P 31/00 |
| (11) | Number of the document | 3261658 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16708853.3 |
| Date of filing the European patent application | 2016-02-18 | |
| (97) | Date of publication of the European application | 2018-01-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/018396 |
| Date | 2016-02-18 |
| (87) | Number | WO 2016/137806 |
| Date | 2016-09-01 |
| (30) | Number | Date | Country code |
| 201562119592 P | 2015-02-23 | US |
| (72) |
BARRIERE, Steven L., US
LO, Arthur, US
MAMMEN, Mathai, US
WORBOYS, Philip, US
|
| (73) |
Cumberland Pharmaceuticals Inc.,
2525 West End Avenue Suite 950, Nashville, TN 37203,
US
|
| (54) | DOSES AND METHODS OF ADMINISTERING TELAVANCIN |
| DOSES AND METHODS OF ADMINISTERING TELAVANCIN |